In many clinical areas, early consultant-led intervention has been shown to improve clinical and patient-reported outcomes and to reduce overall treatment costs. This paper reconfirms this finding in the treatment of wet age-related macular degeneration (wet AMD) and presents data from a publicly funded NHS fast-track (FT) centre in north-west England that aims to see and treat patients within 48 hours of referral.
With its higher costs, FLACS failed to provide an additional benefit over phacoemulsification for patients or in healthcare settings, despite its advanced capabilities.
Steroids are an important second-line treatment for the treatment of diabetic macular oedema. While side effects remain a concern, modern formulations of intravitreal steroid allow the treatment to be tailored to the individual patient.
In many clinical areas, early consultant-led intervention has been shown to improve clinical and patient-reported outcomes and to reduce overall treatment costs. This paper reconfirms this finding in the treatment of wet age-related macular degeneration (wet AMD) and presents data from a publicly funded NHS fast-track (FT) centre in north-west England that aims to see and treat patients within 48 hours of referral.
Current IOL designs offer a variety of optical options for the correction of presbyopia. Regardless of the principal of correction, compromise is required. However, a new class of IOLs, currently referred to as extended-depth-of-focus IOLs (EDOF-IOLs), seems to be generating very satisfied patients.
An I/A tip system comprises a preassembled, single-use silicone I/A tip, which has advantages over other commercially available products. It helps to reduce capsular rupture during cataract surgery and also eliminates tricky tip assembly and cleaning.
Although the diagnosis of primary congenital or early developmental glaucoma is often straightforward, similar phenotypic features can occur in other paediatric conditions, which are consequently sometimes mistaken for early childhood glaucoma. Ophthalmologists who care for children with glaucoma must keep such potential mimics in mind.
Ocular surface disease, including dry eye disease, is common in patients undergoing cataract surgery. It must be treated in order to optimise the ocular surface prior to surgery, and close follow-up in the postoperative period is important.
Cataract surgery assisted by viscosplit and crack with a new phaco tip gives good results compared with standard phacoemulsification, either bimanual or one-handed.
A new double-arc intrastromal corneal ring segment may help to improve visual outcomes and rehabilitate the physiologic optical surface by remodelling the cornea
A new double-arc intrastromal corneal ring segment may help to improve visual outcomes and rehabilitate the physiologic optical surface by remodelling the cornea
A new double-arc intrastromal corneal ring segment may help to improve visual outcomes and rehabilitate the physiologic optical surface by remodelling the cornea
The Nd:YAG laser plays a key part in ophthalmology. However, it is important to select a device that enables the best treatment results using lower energy and fewer shots
Mild cases of retinopathy of prematurity may improve without treatment, but some cases require treatment to keep ROP from causing significant visual impairment and even blindness.
In this article, the authors discuss how WF?guided and WF-optimized LASIK performed on hyperopic patients can provide similar results in terms of safety, contrast sensitivity and refractive error.
In SMILE the anterior-most stromal lamellae remain intact postoperatively. Here, the author discusses the biomechanical advantages of preserving the stronger anterior stroma and the resulting effects on spherical aberration control and optical quality.
Five years of experience with the Rayner T-flex aspheric IOL show it to be a safe, highly effective long-term method of correcting the widest possible range of sphere and cylinder errors in pseudophakic patients with pre-existing corneal astigmatism.
Members of the Ophthalmology Times Europe® Editorial Advisory Board were asked to predict developments in their ophthalmic specialties and interests for 2023. A focus is our ageing population, while efficiency and productivity are also on their minds. The board members agree that one of the major challenges in the year to come will be the large number of patients awaiting diagnosis and treatment, which is only going to increase with the rising average life expectancy worldwide.
Corneal asphericity, OCT angiography, and balance control issues in glaucoma patients are analyzed in this industry update roundup.
While traditional transscleral cyclophotocoagulation is effective at lowering IOP in patients with glaucoma, it has a high rate of side effects. The new MicroPulse system is effective and affordable with an excellent safety profile.
Patients are at risk for developing severe dry eye and ocular surface disease.
The incidence was comparable to that of daily wear soft contact lenses
Diabetes doubles the risk of cataract in the general population, with an even greater increased risk among people aged under 70, according to researchers.
A committee of the European Medicines Agency has recommended approval of cenegermin (Oxervate, Dompé) eye drops for neurotrophic keratitis.